Ann Arbor, MI, United States of America

David T Connor

Average Co-Inventor Count = 3.2

ph-index = 16

Forward Citations = 966(Granted Patents)

Forward Citations (Not Self Cited) = 887(Sep 21, 2024)

DiyaCoin DiyaCoin 0.31 

Inventors with similar research interests:


Location History:

  • Parsippany, US (1976)
  • Parsippany, NJ (US) (1976 - 1979)
  • Ann Harbor, MI (US) (2001)
  • Ann Arbor, MI (US) (1978 - 2007)


Years Active: 1976-2007

where 'Filed Patents' based on already Granted Patents

150 patents (USPTO):

Title: David T Connor: Pioneering Innovator with 150 Patents

Introduction:

David T Connor is a highly esteemed inventor and innovator based in Ann Arbor, Michigan. With an impressive portfolio of 150 patents, Connor has made significant contributions to various industries. This article will explore his latest patents, career highlights, noteworthy collaborations, and the impact of his groundbreaking work.

Latest Patents:

1. Isophthalic acid derivatives as matrix metalloproteinase inhibitors:

Connor's invention focuses on isophthalic acid derivatives as selective inhibitors of matrix metalloproteinase-13 (MMP-13). These inhibitors have the potential to be used in various therapeutic applications, with MMP-13 playing a crucial role in the development of several diseases and conditions.

2. MCP-1 receptor antagonists and methods of use thereof:

This innovative patent revolves around sulfones that act as MCP-1 receptor antagonists. These compounds have shown potential in treating chemokine-mediated disorders, offering new avenues for therapeutic interventions in various diseases.

Career Highlights:

Throughout his career, David T Connor has demonstrated exceptional expertise and dedication in his field. His contributions have been instrumental in pushing the boundaries of scientific research and development. Notably, Connor has worked with renowned companies, including:

1. Warner-Lambert Company (now part of Pfizer Inc.): Connor contributed significantly to the company's research and development efforts, focusing on novel therapies and treatment options.

2. Other Companies: Connor's expertise and knowledge have been invaluable to numerous other companies, where he applied his skills and developed groundbreaking technologies. Unfortunately, specific details regarding these companies are not available at this time.

Collaborations:

Innovation thrives on collaboration, and David T Connor has had the opportunity to work with exceptional individuals during his career. Two notable colleagues who have collaborated closely with Connor include:

1. Paul C Unangst: Unangst has been an essential collaborator with Connor, bringing diverse expertise to their joint projects. Together, they have contributed to advancements in the field, enhancing the treatment options available for various diseases.

2. Roderick J Sorenson: Sorenson's collaboration with Connor has resulted in significant breakthroughs. Their joint efforts have not only shaped industries but also paved the way for more effective therapeutic approaches.

Conclusion:

David T Connor's lasting impact on the world of innovation and patents cannot be understated. With an impressive catalog of 150 patents and a career marked by exemplary contributions, Connor has cemented his name among the pioneers of scientific discovery. His dedication to advancing therapeutic options and groundbreaking technologies has influenced multiple industries. As his work continues to inspire future generations, the legacy of David T Connor will undoubtedly shape the future of innovation and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…